World Liver Day is coming soon on April 19, 2026 !! Please get involved in its campaign through the following site !! World Liver Day 2026: Solid Habits, Strong Liver  

APASL STC 2026 Singapore will be held on July 9-12, 2026 !! Please keep updated on its latest information through the following link or QR code !! https://themeetinglab.eventsair.com/apasl-stc-2026?fbclid=IwY2xjawPw5SRleHRuA2FlbQIxMABicmlkETFCc0dRYm1sajVGZ2N4d1NNc3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHpH-WE-y3LQ2nOf9Idq-y_qH3vWek6heWYscvwagquL4QQsF3RsqO8b4PJ-A_aem_W8oXUzoL-iKUj0MN51UwuA

APASL STC 2026 New Delhi  with the theme of  < Wilson India 2026 > has been held successfully !! We would like to thank you all for making this conference remarkable and fulfilling !! We look forward to seeing you all in another APASL conference !!

We are delighted to announce that the application for APASL Named Award and Rising Star Award has been extended to February 15, 2026 !! Please check out the following details and get ready for your application !!   Named Awards 1) APASL Okuda-Omata Distinguished Award 2) APASL Powell-Sarin Achievement Award 3) APASL Lesmana-Sollano Great Mentor Award APASL will offer USD 5,000 for each.   <Selection Criteria for Named Awards> Presenters will be selected based upon the following criteria High original scientific research and achievements in a given area of liver diseases Continuous Contribution to APASL Activities Leadership role in academics and science in the field of Hepatology Persons with at … [Read more]

APASL STC New Delhi has just started ！！ With the theme of “Wilson Disease : New Concepts in Diagnosis and Management”, APASL STC 2026 New Delhi is being held until January 31, 2026 !! We are waiting for your participation !!

Read the findings from the ANCHOR randomized controlled trial, evaluating the efficacy and safety of combination therapy with entecavir, peginterferon alfa-2b, and GM-CSF. This important study provides robust clinical evidence on combination treatment strategies aimed at improving outcomes in chronic hepatitis B management. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10977-2 #HepatitisB #HBV #CombinationTherapy #ClinicalTrials #Hepatology #AntiviralTherapy #Immunomodulation #HepatologyInternational #MedicalResearch #HealthcareProfessionals

We are so thrilled to announce that APASL 2027 Sydney will be held on April 1-4, 2027 !! Please save the date for the once-a-year large scale conference in the beautiful city of Sydney !!

Abstract Submission Deadline is Jan 20, 2026 !! SO MANY Abstracts have been submitted so far, we look forward to receiving YOUR Abstracts !! https://www.apasl-oncology2026tokyo.org/abs.html Good News！！ Late Breaking Abstract Submission is available until February 10, 2026 !! We hope this will help you submit as many abstracts as possible !!

Abstract Submission Deadline has been extended to Jan 20, 2026 !! APASL Oncology 2026 Tokyo is waiting for your active involvement !! https://www.apasl-oncology2026tokyo.org/abs.html

With the theme of Wilson India 2026~ Integrating Research into Clinical Practice in Wilson Disease ~, APASL STC 2026 New Delhi will be held on Jan 30-31 !! This is our FIST STC in 2026 !! Please register to participate and get enough intellectual incentive for further development during this year !! Please visit the following URL for its details !! https://www.ilbs.in/?page=content&itemid=756

Call for Bidding !! APASL Annual Meeting in 2029 and APASL STC/Oncology in 2027 At this time, we would like to announce you that APASL will conduct a bidding process to decide the host country of APASL future meetings (APASL Annual Meeting in 2029 and APASL STC/Oncology in 2027) during APASL Annual Meeting 2026 Istanbul. The bidding will be performed at APASL Steering Committee Meeting. The date & time and place of APASL Steering Committee Meeting will be announced to the bidders later.   Bidding for Annual Meeting in 2029 and APASL STC/Oncology in 2027- *Bidding will be held during Steering Committee Meeting of APASL. *The assemble time for bidders … [Read more]

Read the findings from the ANCHOR randomized controlled trial, evaluating the efficacy and safety of combination therapy with entecavir, peginterferon alfa-2b, and GM-CSF. This important study provides robust clinical evidence on combination treatment strategies aimed at improving outcomes in chronic hepatitis B management. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10977-2 #HepatitisB #HBV #CombinationTherapy #ClinicalTrials #Hepatology #AntiviralTherapy #Immunomodulation #HepatologyInternational #MedicalResearch #HealthcareProfessionals

APASL STC 2026 Wilson India will be held in New Delhi on January 30-31 !! Let’s start the new year with our exciting and fulfilling conference !!

CALL FOR ABSTRACTS – APASL-ONCOLOGY 2026 TOKYO https://www.apasl-oncology2026tokyo.org/ 📅 April 2–3, 2026 | University of Tokyo Abstract submission is now OPEN!We invite clinical, surgical, interventional, oncology, and basic research abstracts. ✨ Young Investigator Award: 20 Awards– Age ≤40– Must complete Early Bird Submitted by Dec 25, 2025(Christmas Day !)– First author & presenter required 🎥 Video Session Open!TACE / TARE / HAIC / RFA / MWA / EUS-BD / ERCP / Surgery / Transplantation 🗓 Deadline: Dec 31, 2025(Short extension may be considered) Join us in Tokyo and shape the future of liver cancer care!

APASL STC 2025 Yangon was held successfully !! We greatly appreciate your enthusiasm and devotion to bring about this success to the conference !! We hope you had a fulfilling and exciting time at the conference !!